Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
E Peverelli, E Giardino, D Treppiedi, M Meregalli, M Belicchi, V Vaira, S Corbetta, C Verdelli, E Verrua, A L Serban, M Locatelli, G Carrabba, G Gaudenzi, E Malchiodi, L Cassinelli, A G Lania, S Ferrero, S Bosari, G Vitale, Y Torrente, A Spada, G Mantovani
International journal of cancer 2017;140(8):1870-1880